# Setmelanotide (Imcivree) for rare genetic forms of obesity.

> PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34544109-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-09-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34544109-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34544109-setmelanotide-v1.json
- Content SHA-256: `19d34b2f83c9ecc69c5e013b91b1eec9bb00634e0b505b22ab955895ce937ec6`

## Claims and source pins

### Headline

Setmelanotide (Imcivree) for rare genetic forms of obesity. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

### Summary

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

### Paragraph 1

PubMed lists PMID 34544109 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2021-07-26 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`](#source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042))

## Sources

<a id="source-pubmed-observation-pmid-34544109-2021-09-28-916f0e404042"></a>
- **Setmelanotide (Imcivree) for rare genetic forms of obesity. · retained source version 1:2021-09-28:current:916f0e404042939b035f3cabb3bb7fc592001cc3ea454a2362c6be24e22babea** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34544109/) (`pubmed-observation-pmid-34544109-2021-09-28-916f0e404042`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Setmelanotide (Imcivree) for rare genetic forms of obesity." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34544109-setmelanotide-v1.json SHA-256: 19d34b2f83c9ecc69c5e013b91b1eec9bb00634e0b505b22ab955895ce937ec6.